Headquartered in London with offices in the US, ai.io is an award-winning technology company that develops technology solutions to generate & analyse amateur & professional sport data, providing real-time analysis & reporting, creating valuable insights & outcomes.Our core product ecosystem includes:• aiScout: A talent analysis and development platform that will provide teams and organisations the opportunity to reach, engage, analyse, rate, score, trial, develop and scout amateur players from around the world who have access to a mobile phone. The platform consists of a player app, scout app and recruitment control center. The aiScout player app is available for download at Google Play & Apple’s app store.• aiLabs: Multi-use elite performance labs that house state-of-the-art technology and gold standard equipment that provide professional and amateur players and club staff real time physical and cognitive analysis, usable insights and outcomes and connected data.

Leading a team responsible for delivering sport technology to the Olympic Games, including 3D Athlete Tracking (3DAT). Our technologies are used to improve athlete performance through coaching / training solutions and to enhance fan engagement through broadcast graphics and analysis.Fast Company’s The 10 most innovative companies in sports in 2022

Led a team responsible for defining Intel's technology strategy in wearables. Leveraged and proposed sensor and algorithm technology to create amazing products. Developed strategic partnerships with industry and research collaborators to explore new uses and markets.

Built and led a multidisciplinary R&D team to create multiple generations of health and fitness trackers. Utilizing expertise in noninvasive sensing, digital signal processing, and machine learning, the Basis R&D team created technology for cutting edge wearables: class-leading optical heart rate sensing and energy expenditure measurement, the first to measure sleep and sleep stages automatically from the wrist, and the first to automatically detect exercise activities.

Led team of scientists at medical device start-up developing microneedle-based continuous glucose monitor for treatment of diabetes. Oversaw research clinical studies investigating device-skin interface, development of algorithms for prediction of glucose readings, and statistical analysis strategy for regulatory submission.

Core member of team that developed a novel iontophoretic platform to non-invasively deliver compounds to the back of the eye, bringing concept to prototype achieving in vivo delivery of therapeutic levels for three product candidates.

Scientist on R&D team developing multiple generations of the GlucoWatch, the first FDA-approved non-invasive continuous glucose monitor. Designed clinical studies investigating sensor performance and developed algorithm components and statistical analyses.